Clinical outcome and safety of rituximab therapy for pemphigoid diseases
Saved in:
Main Authors: | Napatra Tovanabutra, Aimee S. Payne |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85080075217&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/68526 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Factors Associated with Complete Remission after Rituximab Therapy for Pemphigus
by: Carolyn J. Kushner, et al.
Published: (2020) -
Prevalence and clinical features of thai patients with bullous pemphigoid
by: Kanokvalai Kulthanan, et al.
Published: (2018) -
Bullous pemphigoid treated with intravenous immunoglobulin
by: Papapit Tuchinda, et al.
Published: (2018) -
Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid: A comparative study of 100 patients with bullous pemphigoid and diabetes mellitus
by: Kumutnart Chanprapaph, et al.
Published: (2022) -
The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease
by: Marco, H, et al.
Published: (2020)